Intellectual Property India Publishes Patent Application for 'Heterocyclic Compound As Tyk2 Inhibitor, And Synthesis And Use Thereof' Filed by Zhejiang Wenda Pharmaceutical Technology Co. Ltd.

MUMBAI, India, June 6 -- Intellectual Property India has published a patent application (202517023575 A) filed by Zhejiang Wenda Pharmaceutical Technology Co. Ltd., Zhejiang, China, on March 17, for 'heterocyclic compound as tyk2 inhibitor, and synthesis and use thereof.'

Inventor(s) include Wang, Nenghui.

The application for the patent was published on June 6, under issue no. 23/2025.

According to the abstract released by the Intellectual Property India: "Provided in the present invention are a heterocyclic compound as a TYK2 inhibitor, and the synthesis and use thereof. Specifically, provided is a compound or a pharmaceutically acceptable salt thereof. The compound is as represented by formula A, and each group is as defined herein." ...